Fulgent Genetics (FLGT) Short-term Investments (2016 - 2025)
Fulgent Genetics' Short-term Investments history spans 10 years, with the latest figure at $285.9 million for Q4 2025.
- For Q4 2025, Short-term Investments rose 40.86% year-over-year to $285.9 million; the TTM value through Dec 2025 reached $285.9 million, up 40.86%, while the annual FY2025 figure was $285.9 million, 40.86% up from the prior year.
- Short-term Investments for Q4 2025 was $285.9 million at Fulgent Genetics, up from $258.2 million in the prior quarter.
- Across five years, Short-term Investments topped out at $446.7 million in Q4 2022 and bottomed at $155.0 million in Q3 2024.
- The 5-year median for Short-term Investments is $270.8 million (2021), against an average of $297.3 million.
- The largest annual shift saw Short-term Investments surged 1429.02% in 2021 before it plummeted 59.6% in 2024.
- A 5-year view of Short-term Investments shows it stood at $285.6 million in 2021, then soared by 56.41% to $446.7 million in 2022, then fell by 26.87% to $326.7 million in 2023, then plummeted by 37.87% to $203.0 million in 2024, then surged by 40.86% to $285.9 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Short-term Investments are $285.9 million (Q4 2025), $258.2 million (Q3 2025), and $205.0 million (Q2 2025).